SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-24-000711
Filing Date
2024-02-14
Accepted
2024-02-14 12:24:04
Documents
35
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q agtx_10q.htm   iXBRL 10-Q 501489
2 CERTIFICATION agtx_ex311.htm EX-31.1 10600
3 CERTIFICATION agtx_ex312.htm EX-31.2 10574
4 CERTIFICATION agtx_ex321.htm EX-32.1 4735
  Complete submission text file 0001477932-24-000711.txt   1925626

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA agtx-20231231.xsd EX-101.SCH 18240
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE agtx-20231231_lab.xml EX-101.LAB 120405
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE agtx-20231231_cal.xml EX-101.CAL 26823
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agtx-20231231_pre.xml EX-101.PRE 94470
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE agtx-20231231_def.xml EX-101.DEF 39261
37 EXTRACTED XBRL INSTANCE DOCUMENT agtx_10q_htm.xml XML 171788
Mailing Address 32932 PACIFIC COAST HIGHWAY #14-254 DANA POINT CA 92629
Business Address 32932 PACIFIC COAST HIGHWAY #14-254 DANA POINT CA 92629 321-229-2014
Agentix Corp. (Filer) CIK: 0001603345 (see all company filings)

IRS No.: 462876282 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-55383 | Film No.: 24634955
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)